Stem cell therapy in multiple sclerosis: Promise and controversy

Multiple Sclerosis

Volumn 14, Issue 4, 2008, Pages 541-546

  Duncan, I D ^a   Goldman, S ^b   Macklin, W B ^c   Rao, M ^d   Weiner, L P ^e   Reingold, Stephen C ^f  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Invitrogen Corporation   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Scientific and Clinical Review Associates LLC   (United States)

Author keywords

Multiple sclerosis; Stem cells; Therapy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEU DIFFERENTIATION FACTOR; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL RESEARCH; CLINICAL TRIAL; DEGENERATIVE DISEASE; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; HEALTH CARE ORGANIZATION; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MULTIPLE SCLEROSIS; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; REMYELINIZATION; WORKSHOP;

CLINICAL TRIALS AS TOPIC; HUMANS; MULTIPLE SCLEROSIS; NEUROBIOLOGY; STEM CELL TRANSPLANTATION;

EID: 46749120657     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507087324     Document Type: Article

References (10)

1. Weissman, IL. Stem cells - scientific, medical and political issues. N Engl J Med 2002; 346: 1576-1579.
2. Wertz, DC. Embryo and stem cell research in the USA: a political history. Trends Mol Med 2002; 8: 143-146.
3. Singec, I, Janidal, R, Crain, A, Nikkhah, G, Snyder, EY. The leading edge of stem cell therapeutics. Annu Rev Med 2007; 58: 313-328.
4. Hsu, Y-C, Lee, D-C, Chiu, I-M. Neural stem cells, neural progenitors and neurotrophic factors. Cell Transplant 2007; 16: 133-150.
5. Magnus, T, Rao, MS. Neural stem cells in inflammatory CNS diseases; mechanisms and therapy. J Cell Mol Med 2005; 9: 303-319.
6. Goldman, SA, Windrem, MS. Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1463-1475.
7. Lindvall, O, Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 2006; 441: 1094-1096.
8. Keirstead, HS. Stem cells for the treatment of myelin loss. Trends Neurosci 2005; 28: 677-683.
9. Brüstle, O, Jones, KN, Learish, RD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285: 754-756.
10. Kohama, I, Lankford, KL, Periningerova, J, White, FA, Vollmer, TL, Kocsis, JD. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001; 21: 944-950.